Investegate announcements from HMNC Holding GmbH, HMNC Brain Health to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond on June 27, 2022
HMNC Brain Health to Participate in H.C. Wainwright Bioconnect Conference in January 2022MUNICH, Germany, Jan. 06, 2022 (GLOBE NEWSWIRE) HMNC Brain Health (“HMNC” or the “Company”), a clinical stage precision psychiatry biopharma company, pioneering the development of personalized therapie.